Original Research
Accepted on 15 Jul 2024
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of "ilmiovaccinoCOVID19 collaborating group"
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1363086
Volumes
62 Publications
Volume 4 - 2024
Original Research
Published on 27 Jun 2024
Assessing the performance of large language models in literature screening for pharmacovigilance: a comparative study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1379260
- 404 views
Original Research
Accepted on 20 Jun 2024
Measurement Error and Bias in Real-World Oncology Endpoints when Constructing External Control Arms
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1423493
Original Research
Published on 13 May 2024
Progressive multifocal leukoencephalopathy reports in rheumatoid arthritis concerning different treatment patterns-an exploratory assessment using the food and drug administration adverse event reporting system
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1334468
- 346 views
Methods
Published on 11 Apr 2024
Application of the target trial emulation framework to external comparator studies
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1380568
- 1,110 views
Opinion
Published on 03 Apr 2024
Regulation 2017/745 on medical devices, two major innovations: 1) the physiological action of devices consisting of natural materials such as vegetal matrices; 2) the chemical-physical-mechanical action of devices made of “substances”, which as such are artificial derivatives
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1389406
- 427 views
Original Research
Published on 20 Mar 2024
Machine learning analysis of patients’ perceptions towards generic medication in Greece: a survey-based study
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1363794
- 496 views
Review
Published on 18 Mar 2024
Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: challenges and opportunities
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1356405
- 1,759 views
Editorial
Published on 06 Feb 2024
Editorial: Traditional and innovative approaches for signal detection
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1373689
- 498 views
Editorial
Published on 05 Feb 2024
Editorial: Treatment of comorbidities of asthma and its safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1366847
- 524 views
Systematic Review
Published on 31 Jan 2024
Menstrual disorders following COVID-19 vaccination: a review using a systematic search
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1338466
- 1,476 views
Volume 3 - 2023
Perspective
Published on 02 Feb 2024
External comparators and estimands
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1332040
- 990 views
- 1 citation
Review
Published on 26 Jan 2024
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1323057
- 3,597 views
- 9 citations
Perspective
Published on 24 Jan 2024
External Comparator Cohort studies - clarification of terminology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1321894
- 1,399 views
Review
Published on 21 Dec 2023
A review of the prescribing culture of anti-depressants across government districts in Northern Ireland
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1303572
- 807 views
Review
Published on 14 Dec 2023
Safety of corticosteroid therapy in sarcoidosis treatment
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1319931
- 544 views